Introduction
Lymphoma of the ovary can be either primary or secondary with primary ovarian lymphoma (POL) having a better prognosis than secondary lymphoma. [1] negative for infection. She tested negative for hepatitis B surface antigen, dengue NS1 antigen, and HIV 1 and 2.
Ultrasound scan and CT abdomen revealed a large complex adnexal mass of 71 × 54 mm in size with enlarged bilateral pelvic lymph nodes and enlarged para-aortic lymph node masses encasing aorta and common iliac vessels. CT of the chest was normal.
She underwent explorator y laparotomy, bilateral salpingo-oophorectomy and omentectomy [ Figure 1 ]. There were enlarged pelvic and para-aortic lymph nodes noted at surgery. Hysterectomy was not performed due to technical difficulty in the presence of enlarged lymph nodes. Histology confirmed diffuse large B-cell NHL of the ovary. Immunohistochemical assays were positive for CD 20, CD 3 with 30-40% proliferative activity with Ki 67. Bone marrow trephine biopsy revealed a normocellular marrow.
The patient underwent six cycles of chemotherapy with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone (R-CHOP) regime. A repeat CT after four cycles of chemotherapy showed a good response with the absence of enlarged pelvic nodes. She completed six cycles of chemotherapy and the latest CT scan revealed no residual disease.
Discussion
Ovaries can be affected in lymphoma by either primary or secondary involvement. The usual age at presentation in women is in their fifth decade. [3, 4] Ovarian lymphoma is known to occur in younger females. [5] Most of the primary and secondary ovarian lymphomas are diagnosed incidentally. Patients may present with B symptoms (fever, night sweats, and weight loss) as in the case of our patient. [3] Most often the patients present to the primary care physician with these symptoms and the possibility of lymphoma should be considered when there is poor response to initial treatment.
Our patient presented with fever and abdominal pain for 3 weeks. The clinical examination and high CRP was suggestive of a pelvic infection, for which she was initially treated with poor response. Elevated serum LDH levels together with enlarged pelvic lymphadenopathy led to the suspicion of lymphoma.
Patients with inflammatory bowel disease are at risk of other malignancies, lymphoma being one of them. [6] It is important for the primary care physician to be aware of the possibility of developing malignancies in patients with inflammatory bowel disease. Cohort studies in patients with ulcerative colitis have not shown an increased risk of developing lymphoma due to the disease itself, [7] but there is evidence that immunomodulators such as azathioprine and antitumor necrosis factor treatment can increase the risk of lymphoma. [7] However, sulfasalazine, which is also an immunomodulator, has shown inhibitory effects on lymphoma cell proliferation in vitro studies. [8] It is unusual that our patient developed NHL of the ovary despite being on sulfasalazine for 22 years with its known anti-proliferative effect. [8] She had never been on other immunosuppressants such as azathioprine. Although patients with ulcerative colitis are known to have an increased risk of ovarian cancer, [9] a higher risk of ovarian lymphomas has not been reported. This is the first report of an ovarian lymphoma arising in a patient with longstanding ulcerative colitis treated with sulfasalazine, although a causal association cannot be established.
POL is usually diagnosed by using the criteria laid down by
Fox et al. [10] According to these criteria, POL can be diagnosed when (a) the disease is confined to ovary and investigations fail to reveal lymphoma elsewhere. It is considered primary even when only immediately adjacent lymph nodes are involved, (b) absence of abnormal cells in peripheral blood and bone marrow, (c) newer extra ovarian deposits if any should appear at least 6 months after the detection of the primary site. [10] Our patient had only ovarian and its adjacent draining lymph node involvement, normal bone marrow biopsy and absent abnormal cells in the peripheral blood fit into the diagnosis of POL.
The disease is staged based on Ann Arbour classification to provide prognostic information as well as to assist therapeutic decision-making. [10] Our patient was classified as having stage III B lymphoma. The management is done usually after confirmation of diagnosis by biopsy and chemotherapy in contrast to more radical surgery undertaken in other ovarian malignancies. Lymphoma of the ovary should be considered as a differential diagnosis when women around 40-50 years of age present with an adnexal mass.
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